🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Validation of a Digital Intervention to Rehabilitate Cognitive Resources

RecruitingNAAges 65 Years - anyAllFondazione Don Carlo Gnocchi ETS
NCT07064226 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn if the use of a digital cognitive rehabilitation system named RICORDO, that is flexible and capable of adapting the rehabilitation pathway according to the needs and capacity of the patients will prove effective for subjects with Subjective Memory Complaint or with Mild Cognitive Impairment or with Mild Dementia. The main questions it aims to answer are: Will the RICORDO rehabilitation treatment, lead to an improvement in the global cognitive level? Will the RICORDO rehabilitation treatment lead to improved activation of participants in managing their own health and healthcare? Researchers will compare the multidomain cognitive rehabilitation strategy of RICORDO digital solution, with a standard paper pencil rehabilitation care (usual care). Participants will undergo a comprehensive neuropsychological evaluation immediately before, immediate

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Montreal Cognitive Assessment (MoCA) score \> 17.79; 2. Clinical Dementia Rating (CDR) Scale score ≤ 1; 3. Education level \> 3 years; 4. Age ≥ 65 years; 5. Informed consent to participate, confirmed by signing the consent form; 6. Availability of a caregiver/study partner able to support the participant; 7. Stable pharmacological treatment (past 3 months) with acetylcholinesterase inhibitors, if applicable. Exclusion criteria: 1. Presence of dysmetria or marked auditory/visual or communication disorders preventing the participation to the trial; 2. Presence of ongoing rehabilitation program at the time of enrollment or in the 3 months prior to enrollment;
💊

What it tests

  • RICORDO
  • Treatment as Usual (TAU)
📍

Where

1 site
IRCCS Fondazione Don Carlo Gnocchi ONLUS; Center of Advance Diagnostic and Therapy ( CADiTeR)
Milan, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy